Unlock instant, AI-driven research and patent intelligence for your innovation.

Process for preparation of substituted pyrazole derivatives

A technology of pyrazole and mixture, applied in the field of preparing substituted pyrazole derivatives, can solve problems such as high reaction temperature, influence on industrial-scale synthesis of compound of formula I, low yield and the like

Pending Publication Date: 2022-03-04
F HOFFMANN LA ROCHE & CO AG
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The synthesis of 5-ethyl-4-methyl-1H-pyrazole-3-carboxylic acid (1) described by Skinner et al. has several disadvantages, such as low yields and high reaction temperatures, which ultimately affect the procedure according to WO2017157873 Carried out industrial-scale synthesis of compounds of formula I

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparation of substituted pyrazole derivatives
  • Process for preparation of substituted pyrazole derivatives
  • Process for preparation of substituted pyrazole derivatives

Examples

Experimental program
Comparison scheme
Effect test

example

[0146] The present invention will be more fully understood by reference to the following examples. However, the claims should not be construed as limiting the scope of the examples.

[0147] If not stated otherwise, all reactions were performed under a protective atmosphere such as argon or nitrogen.

example 1

[0149] 5-Ethyl-4-methyl-1H-pyrazole-3-carboxylic acid (1)

[0150] 3-Pentanone (93.0 g, 1.08 mol, 1.20 eq) was added to diethyl oxalate (132 g, 903 mmol, 1.00 eq) in 20% sodium ethoxide ethanol solution (338 g, 994 mmol, 1.10 eq) and kept precooled ( -5°C-0°C) solution. The line was flushed with ethanol (50 mL). After stirring at this temperature for 2 h, the reaction mixture was cooled to about -15 °C and a cold solution of 40% aqueous hydrazine (118 g, 948 mmol, 1.05 eq) in acetic acid (59.7 g, 994 mmol, 1.10 eq) was added dropwise over 2 h ( About 0 ℃) solution, ensure that the reaction temperature does not exceed 0 ℃. Stirring was continued for 1 h. Keeping the internal temperature between 0 and 15°C, a 50% aqueous solution of sodium hydroxide (205 g, 2.57 mol, 2.85 equiv) was added. The solution was stirred at 20°C±5°C for 2h, then at 40°C±5°C for 16h, forming a clear solution. Concentrated (37%) aqueous hydrochloric acid (350 mL, 3.68 mol, 4.07 equiv) was added at 4...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a process for the manufacture of 5-ethyl-4-methyl-N-[4-[(2S) morpholin-2-yl] phenyl]-1H-pyrazole-3-carboxamide (Formula I) or a pharmaceutically acceptable salt thereof on an industrial scale, said process comprising a one-pot process for the manufacture of 5-ethyl-4-methyl-1H-pyrazole-3-carboxylic acid (1).

Description

technical field [0001] The present invention relates to a method for the manufacture of 5-ethyl-4-methyl-N-[4-[(2S)morpholin-2-yl]phenyl]-1H-pyrazole-3-formamide (formula I ) or a novel method of a pharmaceutically acceptable salt thereof. [0002] Background technique [0003] The compound of formula I is a TAAR1 inhibitor, which can be used in the treatment of various diseases and disorders, such as depression, anxiety, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, schizophrenia, Pa Kinson's Disease, Alzheimer's Disease, Epilepsy, Migraine, Hypertension, Substance Abuse, Addiction, Eating Disorders, Diabetes, Diabetic Complications, Obesity, Dyslipidemia, Disorders of Energy Expenditure and Assimilation, Disorders and Disorders of Body Temperature Homeostasis , sleep and circadian rhythm disorders, and cardiovascular disorders (PCT application WO2017157873). [0004] WO2017157873 discloses a method for preparing a compoun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D413/12C07D231/14
CPCC07D413/12C07D231/14A61K31/5377
Inventor 保罗·斯珀尔勒内·特鲁萨尔迪
Owner F HOFFMANN LA ROCHE & CO AG